cyproterone acetate has been researched along with Adenoma, Hepatocellular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feldmann, K; Grunwald, K; Rabe, T; Runnebaum, B | 1 |
Cui, Y; Fujimoto, M; Matsuo, Y; Tachibana, K; Tanae, A; Tanaka, T; Watanabe, S; Yamasaki, S | 1 |
1 review(s) available for cyproterone acetate and Adenoma, Hepatocellular
Article | Year |
---|---|
[Liver tumors in women using oral hormonal contraceptives].
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Female; Humans; Hyperplasia; Liver; Liver Neoplasms; Product Surveillance, Postmarketing; Risk Factors | 1995 |
1 other study(ies) available for cyproterone acetate and Adenoma, Hepatocellular
Article | Year |
---|---|
Follow-up study of children with precocious puberty treated with cyproterone acetate. Ad hoc Committee for CPA.
Topics: Adenoma, Liver Cell; Adolescent; Androgen Antagonists; Carcinoma, Hepatocellular; Child; Child, Preschool; Cyproterone Acetate; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Progesterone Congeners; Puberty, Precocious; Risk | 1997 |